Paper · 40293448
Radiolabeling lipoproteins to study and manage disease.
Pérez-Medina C and 4 others. Eur J Nucl Med Mol Imaging, 2025. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Radiolabeling lipoproteins to study and manage disease. Papers, record 40293448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40293448
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lipoproteins | Major topic |
| Isotope Labeling | Major topic |
| Radiopharmaceuticals | Major topic |
| Humans | |
| Animals |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 AI168258 | NIAID NIH HHS | United States | P01AI168258 | PubMed and NIH | NIH RePORTER |
| P01 HL131478 | NHLBI NIH HHS | United States | P01HL131478 | PubMed and NIH | NIH RePORTER |
| 1P01AI168258-01 | Division of Intramural Research, National Institute of Allergy and Infectious Diseases | P01AI168258 | PubMed and NIH | NIH RePORTER | |
| 2P01HL131478-06A1 | NHLBI Division of Intramural Research | P01HL131478 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References211
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,770,304 | In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II. | J Lipid Res | 1991 | https://conductscience.org/library/papers/1770304 | PubMed |
| 2 | 27,319,780 | Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy. | Nat Commun | 2016 | https://conductscience.org/library/papers/27319780 | PubMed |
| 3 | 8,060,378 | The metabolic fate of apolipoprotein A-I-containing lipoproteins internalized into HepG2 cells: resecreted lipoproteins as a potent inducer for cholesterol efflux. | Atherosclerosis | 1994 | https://conductscience.org/library/papers/8060378 | PubMed |
| 4 | 16,024,913 | HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney. | J Lipid Res | 2005 | https://conductscience.org/library/papers/16024913 | PubMed |
| 5 | 34,503,276 | The Race for Hydroxamate-Based Zirconium-89 Chelators. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34503276 | PubMed |
| 6 | 12,005,032 | Comparison of two methods for radioiodination on the oxidizability properties of low density lipoprotein. | J Physiol Biochem | 2001 | https://conductscience.org/library/papers/12005032 | PubMed |
| 7 | 22,414,908 | Cholesterol efflux assay. | J Vis Exp | 2012 | https://conductscience.org/library/papers/22414908 | PubMed |
| 8 | 8,485,122 | Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia. | Arterioscler Thromb | 1993 | https://conductscience.org/library/papers/8485122 | PubMed |
| 9 | 7,033,286 | Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey. | J Clin Invest | 1981 | https://conductscience.org/library/papers/7033286 | PubMed |
| 10 | 7,316,186 | Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). | Anal Biochem | 1981 | https://conductscience.org/library/papers/7316186 | PubMed |
1 to 10 of 211
See all 211 referencesCited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,064,614 | Targeted PET Imaging of Atherosclerosis via Low-Density Lipoprotein Click Chemistry with Nanoparticles. | Chem Biomed Imaging | 2026 | https://conductscience.org/library/papers/42064614 | PubMed |
| 40,937,965 | Dendrimers Improve Apolipoprotein Nanoparticle mRNA Delivery to Immune Cells. | Adv Mater | 2026 | https://conductscience.org/library/papers/40937965 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40293448
GET https://conductscience.org/api/papers/v1/40293448/references?page=2